Metabolomics in Occupational Asthma

Asthma, Occupational Clinical Trial

Official title:
Pilot Study of Metabolomics in Occupational Asthma

Status Recruiting

Clinical Trial Summary

The project aims to increase the diagnostic accuracy in occupational asthma (OA), with emphasis on Irritant Induced Asthma (IIA). Currently, most patients are evaluated in occupational medicine by comparing the exposure and symptom characteristics with epidemiological data. Biological markers may be present in AA, but presently not in IIA. The majority of cases evaluated are considered as possible IIA, i.e. low-dose multiple exposures. VOC features will be analyzed with the Breath Biopsy® and TD-GS-MS (Owlstone Medical Ltd, UK).

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04301674
Study type	Observational
Source	Oslo University Hospital
Contact	Bato Hammarström, MD/PhD
Phone	+47 230 16667
Email	bato.hammarstrom@ous-hf.no
Status	Recruiting
Phase
Start date	October 15, 2021
Completion date	June 1, 2023

View Details

See also
	Status	Clinical Trial	Phase
	Enrolling by invitation	`NCT05039229` - Measures for Bioaerosol Reduction in the Salmon Industry	N/A
	Completed	`NCT03311048` - Airway Inflammatory Profile Among Cleaning Workers From Different Workplaces	N/A